Learn More
Medchemexpress LLC Nafamostat mesylate | 82956-11-4 | 99.9% | 500 MG

Supplier: Medchemexpress LLC HYB0190A500MG
Nafamostat mesylate (FUT-175) is an anticoagulant and a synthetic serine protease inhibitor. It demonstrates anticancer and antiviral effects by inducing apoptosis through up-regulating the expression of tumor necrosis factor receptor-1 (TNFR1). This compound is also being investigated for its use in addressing the pathological thickening of the arterial wall.
- Acts as an anticoagulant and synthetic serine protease inhibitor
- Demonstrates anticancer and antiviral effects
- Induces apoptosis via TNFR1 up-regulation
- Investigated for treating pathological arterial wall thickening
- Inhibits NF-κB activity and IκBα phosphorylation
- Suppresses invasiveness in specific cell lines
- Exhibits inhibitory effects on neointimal formation in animal models
- Provides antiviral benefits against Zika virus in animal models
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.